The forthcoming 2020 China International Fair for Trade in Services (CIFTIS) will feature a public health zone where a wide variety of products and technologies will be presented, including inactivated vaccines against COVID-19, nucleic acid quick detection systems, and a TCM diagnosis and treatment platform featuring human-machine interaction. The public health zone, themed “Health and Safety for All”, will focus on international cooperation against COVID-19, China's stories in the fight, and the use of TCM in pandemic prevention and control, showcasing relevant achievements along the entire global industry chain. Over 100 exhibitors have confirmed their participation so far, according to the Beijing Municipal Health Commission.
According to Zheng Jinpu, a level-2 inspector with Beijing Municipal Health Commission, 105 enterprises from eight countries and 13 provinces, autonomous regions and municipalities of China will join the event in the public health zone, including 60 offline participants. Among them, 13 are Fortune Global 500 companies and 17 are industrial leaders. With TCM in pandemic prevention and control as a highlight, the zone will exhibit outstanding healthcare solutions and products from pharmaceutical, medical equipment, and health-centered IT enterprises, focusing mainly on the early prevention, detection, management, and treatment of diseases. During CIFTIS, Beijing Municipal Health Commission and the International Health Exchange and Cooperation Center of the National Health Commission of China will jointly hold Beijing International Conference for Public Health Cooperation themed “Fighting against Global Disease Threats with Shared Anti-Epidemic Experience and Practices”, which will serve as an international platform for global health cooperation and experience sharing.
According to Luo Zenggang, deputy director of the Beijing Administration of Traditional Chinese Medicine, the public health zone will bring together more than 40 TCM enterprises and institutions such as China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Beijing TRT Group, and Yiling Pharmaceutical. They will present industry-leading products and technologies online and offline, with a focus on TCM culture and education, scientific and technological innovation, interactive experiences, and achievements in the battle against COVID-19. For example, Beijing TRT Group will bring a map showing the global coverage of its “Fu Zheng Bi Wen Yin”, an oral solution to help prevent infection with the novel coronavirus, the Sizhen (lit. four diagnosis method) device, the Anniu holographic projector, a herbal extractor, and a smart diagnosis and treatment system to provide interactive experience to visitors. It will put on show the English version of the book Guide on Staying Safe from Novel Coronavirus Abroad. In response to the COVID-19 outbreak, Beijing TRT Group set up an expert panel, developed country/region-specific TCM plans for pandemic prevention and control, and launched the “Fu Zheng Bi Wen Yin” preventive oral solution series.
Beijing Administration of Traditional Chinese Medicine will hold the Global Health Industry Knowledge Alliance Forum, Beijing Traditional Chinese Medicine International Development Forum, and the Opening Ceremony of the TCM Day of the 5th CIFTIS & Chinese Overseas TCM Conference. In addition, an Alliance of Famous TCM Doctors' Hometowns for Promoting the TCM Culture and International Development will be set up, and the Proposal for Joint Action to Bring TCM to the World will be released.
During the event, China National Biotec Group (CNBG) will demonstrate its nucleic acid detection reagents, inactivated vaccines, and other products. In the face of the COVID-19 pandemic, CNBG, as a centrally affiliated state-owned enterprise, played a leading role in the battle against the disease and made tireless efforts to develop vaccines. When the vaccine production capacity of the two research institutes under it comes into full operation, a total of 220 million doses of COVID-19 vaccines can be expected to be available each year. Sinovac Biotech Ltd. will display a slew of products including CoronaVac, an inactivated COVID-19 vaccine, Healive, China's first inactivated hepatitis A vaccine to have acquired pre-certification from the WHO, and Inlive, an inactivated EV71 vaccine. In addition, Coyote Bioscience will showcase its Flash20 novel coronavirus nucleic acid detection system. It takes only 30 minutes for the system to test a sample and one minute to load, making it suitable for point-of-care testing (POCT) at hospitals, community healthcare institutions, and other scenarios requiring quick detection, says Li Xiang, founder and CEO of Coyote Bioscience.
